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STREX domainOur previous study reported that cerebrosides from traditional Chinesemedicine Baifuzidirectly interactwith the
STREX domain of BKCa channels, which in turn results in the therapeutic effect of Baifuzi on ischemic stroke. How-
ever, it is not known how cerebrosides in the plasmamembrane could interact with the STREX domain that is in
the cytoplasmic side. Using patch-clamp technique, effects of different cerebrosides on the BKCa channel were
studied by measuring single channel currents in CHO cells expressing wild type or mutated BKCa channels.
Palmitoylation of the STREX domain was removed either by site-directed mutagenesis or pharmacological inhi-
bition. Removal of palmitoylation sites at C646 and C647 by mutating the residues to Ala abolished the ability of
cerebrosides to activate the BKCa channel. In contrast, the mutation neither changed the single channel conduc-
tance nor voltage sensitivity of the channel. Both palmitoylation inhibitors tunicamycin and palmitic acid analog
2-bromopalmitate attenuated the activation of the BKCa channel by cerebrosides. Furthermore, confocal images
on STREX-EGFP fragments demonstrated that STREX fragments no longer associatedwith the plasmamembrane
when the palmitoylation was removed or blocked. These ﬁndings suggest that palmitoylation of the STREX do-
main is necessary for cerebrosides to activate the BKCa channel and provide insight into the mechanism of how
Baifuzi could exert therapeutic effect on ischemic stroke.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Large-conductance voltage- and Ca2+-activated K+ (BKCa, KCa1.1)
channels servenumerous cellular functions, and their dysregulation is im-
plicated in various diseases [1,2]. It has been shown that the BKCa channel
is regulated by many kinds of lipid molecules. In rabbit pulmonary artery
smooth muscle cells, the BKCa channel can be activated by arachidonic
acid and myristic acid [3]. Fatty acids and negatively charged single-
chain lipids increase the BKCa channel activity, whereas sphingosine and
positively charged single-chain lipids suppress their activity [4]. In vascu-
lar myocytes, the application of exogenous phosphatidylinositol 4,5-
bisphosphate (PIP2) to the cytoplasmic side at a physiological concentra-
tion increases the BKCa channel currents [5]. Recently, it has been demon-
strated that long-chain polyunsaturated omega-3 fatty acids such as
docosahexaenoic acid (DHA), could directly activate BKCa channels. The
DHA action is observed in cell-free patches and does not require
voltage-sensor activation or Ca2+ binding but involves destabilization of
the closed conformation of the ion conduction gate [6].
We have previously demonstrated that several kinds of cerebrosides,
including sulfatides [7], Baifuzi-CB (a mixture of cerebrosides obtainedfrom dried tubers of herb Typhonium giganteum Engl., Chinese medicine
Baifuzi) [8] and termitomycesphins A and B (pure cerebrosides from edi-
ble mushroom Termitomyces albuminosus) [9] could activate BKCa chan-
nels. Besides, we have shown that the STREX domain is necessary for
these cerebrosides to activate the BKCa channel [7–9]. Furthermore, we
have reported that Baifuzi reduces transient ischemic brain damage by ac-
tivating BKCa channels through a direct interaction between Baifuzi-CB
and the STREX domain of the BKCa channel [8]. STREX domain is located
in the intracellular C terminus within the linker region between the two
regulators of potassium conductance (RCK) domains of the BKCa channel
(Fig. 1). It is an important domain in the modulation of the BKCa channel
function, such as calcium and voltage sensitivity [10], regulation by pro-
tein phosphorylation [11], hypoxia sensitivity [12] and palmitoylation
[13,14]. Intriguingly, how could cerebrosides in the plasmamembrane in-
teract with the STREX domain in the cytoplasmic side?
Palmitoylation is a reversible post-translational attachment of a
palmitic acid via a hydroxylamine-sensitive thioester linkage onto cys-
teine residues, which is dependent on a large family of protein
palmitoyltransferases (DHHCs) and thioesterases [15]. Protein
palmitoylation is known to play roles in signal transduction and in en-
hancing the hydrophobicity of proteins thus contributing to their mem-
brane association and membrane targeting. Many membrane proteins
use palmitoylation to facilitate dynamic membrane interactions.
Palmitoylation of SNAP-25 is required for initial membrane targeting of
Fig. 1. Schematic model of the role of STREX palmitoylation for the interaction between cerebrosides and STREX domain of the channel. The STREX domain is localized in the linker be-
tween the two RCK domains in the intracellular C terminus. The 59 amino acids of the STREX(WT) and the STREX(C646:647A) mutant are shown between the two arrows, in which
the palmitoylation sites have been underlined. Attachment of palmitates to Cys646 and 647 of the STREX domain results in the integration of STREX to the plasmamembrane to facilitate
its interaction with cerebrosides in the plasma membrane.
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membranes and interaction with Kv1.4 channel. Palmitoylated PSD-95
partitions exclusively with cell membranes, while palmitoylation-
deﬁcient mutants of PSD-95 do not partition as integral membrane pro-
teins [17]. Palmitoylation can regulate the gating and pharmacological
properties of sodiumchannels [18]. Palmitoylation of theKv1.1 potassium
channel at residue C243 modulates its voltage sensing through protein-
membrane interactions [19]. Palmitoylation of the KChIP auxiliary sub-
units controls plasmamembrane localization of their associated channels
[20]. Palmitoylation of the P2X7 receptor controls its expression and
association with lipid microdomains of the plasma membrane [21].
Palmitoylation is also needed for Rac1 function in actin cytoskeleton re-
modeling by controlling its membrane partitioning, which in turn regu-
lates membrane organization [22]. Interestingly, for the BKCa channel, it
has beendemonstrated that the STREXdomain could target to the plasma
membrane by palmitoylation of its two continuous cysteine residues
C646 and C647 [11]. Therefore, we infer that cerebrosides in the plasma
membrane could only interact with the palmitoylated STREX domain as-
sociated with the membrane, which in turn activates the BKCa channel.
In the present study, we appliedmultiple techniques involving elec-
trophysiology, ﬂuorescent imaging and biochemical assays to test the
above inference. Our results demonstrated that the activation of the
BKCa channel by cerebrosides could be abolished by mutation of the
palmitoylation sites within the STREX domain. And palmitoylation in-
hibitors not only attenuated the activation of the BKCa channel by the ce-
rebrosides but also reduced the association of the STREX fragment with
the plasma membrane. These results suggest that palmitoylation in-
duced membrane association of the STREX domain plays a signiﬁcant
role in the BKCa channel activation by cerebrosides.2. Materials and methods
2.1. Channel constructs
The site directed mutagenesis and subcloning were performed on
the chick BKCa channel α-subunit (GenBank accession number
AB072618). The chick BKCa channel gene has been subcloned into the
plasmid vector pcDNA3.1(-). To make the mutant BKCa(C646:647A),the generation of site directed mutagenesis was performed using
QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene).
To generate the STREX-EGFP fusion proteins, a forward primer con-
taining a XhoI restriction site and a reverse primer with a HindIII site
were used to amplify the STREX(WT) or STREX(C646:647A) genes.
The PCR amplicons were digested and ligated into pEGFP-N1 Vector
(Clontech, Palo Alto, CA, USA) so that EGFP is anN-terminal in-frame fu-
sion with the respective STREX(WT) and STREX(C646:647A). All clones
were conﬁrmed by sequencing.
2.2. Cell culture and transfection
Chinese hamster ovary (CHO) cellswere cultured inHam's F-12 nutri-
ent mixture (Gibco) supplemented with 10% fetal bovine serum (Gibco).
Cells were grown in a 37 °C incubator with 5% CO2 humidiﬁed environ-
ment and passaged twice weekly through exposure to 0.05% trypsin
(Gibco) in Dulbecco's phosphate-buffered saline (DPBS; Gibco) solution.
For gene transfection, cells were transferred to sterile glass coverslips in
35-mm Petri dishes. After cell density reached 60–80% conﬂuence, they
were transiently cotransfected with the channel and EGFP genes. Trans-
fectionwas performedwith Lipofectamine and Plus reagents (Invitrogen)
following the manufacturer's instructions. Cells were used for electro-
physiological recordings 24–72 h post transfection. Human Embryonic
Kidney 293 (HEK 293) cells were grown as monolayers on 35-mm Petri
dishes in high glucose Dulbecco's modiﬁed Eagle's medium (DMEM;
Gibco) containing 10% fetal bovine serum. For immunoﬂuorescence as-
says, cells were plated onto gelatin coated glass coverslips. After cell den-
sity reached 60–80% conﬂuence, they were transiently transfected with
STREX(WT)-EGFP or STREX(C646:647A)-EGFP genes. Cells were used
for immunoﬂuorescence assay 12–24 h post transfection.
2.3. Electrophysiology
Experiments were performed as described earlier [7]. Recording
electrodes were pulled from thin walled borosilicate capillary tubes
using a Micropipette puller (model P-10, Narishige) with resistance in
a range of 2–5 MΩ. The pipette solution was Hanks' balanced salt solu-
tion (HBSS; Gibco, inmM): 1.26 CaCl2, 0.49MgCl2, 0.41MgSO4, 5.33 KCl,
0.44 KH2PO4, 4.17 NaHCO3, 137.9 NaCl, 0.34 Na2HPO4 and 5.56
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(pH 7.3 with KOH), and CaCl2. For a desired intracellular concentration
of free Ca2+ ([Ca2+]i), the necessary amount of CaCl2 was calculated
using the online MaxChelator software (http://maxchelator.stanford.
edu/CaEGTA-NIST.htm). Unless stated otherwise, free intracellular cal-
cium concentration was 0.34 μM with 10 mM Ethylene glycol bis(2-
aminoethyl) tetraacetic acid (EGTA). Chloride-coated silver wires con-
nected the pipette to the probe input. The probe of the patch ampliﬁer
was an EPC-10 ampliﬁer (HEKA Elektronic, Lambrecht, Germany). The
output signals were ﬁltered at 2–5 kHz and low-pass ﬁltered at 1 kHz.
Patchmaster softwarewas used for data acquisition and analysis. All ex-
periments were performed at room temperature (20–25 °C). The value
of the single channel open probability (Po) in a patch with multiple
channels was calculated by using TAC 4.1 (HEKA, Germany), based on
the equation: Po = (1 − Pc1/N), where Pc is the probability when all
of the channels are in the closed state, N is the number of channels in
the patch, whichwas estimated from themaximumnumber of channels
observed over a voltage of +50 mV. The single channel currents were
plotted against a series of voltage and ﬁtted to the GHK (Goldman–
Hodgkin–Katz) current equation [23]:
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;
where IK is the K+ current, PK is membrane permeability to K+, Z = 1,
and E is the transmembrane potential. The reversal potential, Erev, is ob-
tained when IK = 0. Then the single channel conductance, G, is calculat-
ed as: G = IK / (E− Erev). Cerebrosides were dissolved in DMSO and
stored as a stock solution at−20 °C, whichwere dilutedwith bath solu-
tion upon use. Theﬁnal concentration of DMSO in the recording solution
did not exceed 0.1% (v/v), which did not affect BKCa channel's
activity [9].
2.4. Imaging assays
For immunoﬂuorescence assays, HEK 293 cells transfected with
STREX(WT)-EGFP or STREX(C646:647A)-EGFP genes were ﬁxed with
4% paraformaldehyde and permeabilized with 0.5% Triton X-100 at
room temperature for 15 min. After blocking with 5% goat serum at
room temperature for 30 min, cells were incubated sequentially with
vimentin antibody (1:100, Sigma Aldrich) for 1 h at room temperature,
and with goat anti-mouse IgG (GAM5492, 1:500, Multisciences) for 1 h
plus 4′,6-diamidino-2-phenylindole (DAPI; C1005, 1:10, Beyotime) in
darkness at room temperature for 10 min. Coverslips were then sealed
onto themicroscope slides using antifademountingmedium. The endo-
plasmic reticulum was labeled by ER-Tracker Red dye (C1041, 1:1000,
Beyotime). Fluorescence images were observed by confocal microscopy
(Olympus IX-81; Olympus FV1000, Tokyo, Japan).
2.5. Statistical analysis
Data analysiswas carried out using SPSS software. Statistical analysis
was performed using paired-sample Wilcoxon signed rank test. Aver-
aged results were expressed as mean ± SEM from at least 6 indepen-
dent experiments. The differences between groups were considered
signiﬁcant when P b 0.05.
3. Results
3.1. Removal of palmitoylation sites in the STREX domain abolished the
ability of cerebrosides to activate the BKCa channel
To test whether palmitoylation of the STREX domain is necessary for
cerebrosides to activate the BKCa channel, we compared the effects of ce-
rebrosides on both wild type BKCa(WT) channels and palmitoylation
sites removed BKCa(C646:647A) channels. Cerebroside concentrationwas chosen as 10 μM in the experiment, because our previous studies
[7–9,24] have shown that most cerebrosides tested could signiﬁcantly
activate the channel at this concentration. Application of 10 μM Baifuzi-
CB to the intracellular face of the membrane increased the BKCa(WT)
channel activity in the most patch membranes. In contrast, Baifuzi-CB
no longer or only weakly activated the BKCa(C646:647A) channel
(Fig. 2A–C). Statistical summary demonstrated that the Po of the
BKCa(WT) channel was increased from 1.6 ± 0.3% of control to
4.8 ± 1.1% (n = 19) upon application of 10 μM Baifuzi-CB at +20 mV,
while 10 μM Baifuzi-CB only slightly increased Po of BKCa(C646:647A)
channels from 1.7 ± 0.5% to 2.5 ± 0.9% (n = 10) (Fig. 2C). Baifuzi-CB
is a mixture of cerebrosides, which differ in length of fatty acid,
saturation, location and conﬁguration of double bonds on long chain
base. Therefore, we examined the effect of 1-O-β-D-glucopyranosyl-
(2S, 3R, 4E, 8Z)-2-[(2′ R)-hydroxydocosanoyl-amino]-4, 8-
octadecadiene-1,3-diol, a single pure cerebroside (single CB), isolat-
ed from mixture of Baifuzi-CB, on BKCa(WT) and BKCa(C646:647A)
channels. As illustrated in Fig. 2D and E, 10 μM single CB signiﬁcantly
increased the Po of the BKCa(WT) channel without signiﬁcant effect
on the BKCa(C646:647A) channel. The Po of BKCa(WT) channels was in-
creased from 1.1 ± 0.3% of control to 3.6 ± 1.0% (n = 17) in the pres-
ence of 10 μM single CB, while 10 μM single CB only increased Po of
the BKCa(C646:647A) channels from 0.7 ± 0.1% to 0.8 ± 0.1% (n = 8)
(Fig. 2F), indicating that the effect of cerebrosides to activate the BKCa
channel was abolished by the removal of the palmitoylation sites in
the STREX domain. To further conﬁrm the importance of palmitoylation
on the BKCa channel activation by cerebrosides, we selected sulfatides,
consisting primarily of galactocerebroside sulfate, for the assay. In
contrast to signiﬁcant increase in the Po of the BKCa(WT) chan-
nel, sulfatides had no signiﬁcant effect on the BKCa(C646:647A)
channel (Fig. 2G and H). The Po of the BKCa(WT) channel was in-
creased from 2.1 ± 0.5% of control to 5.0 ± 1.2% (n = 8) upon
application of 10 μM sulfatides, while the same concentration of
sulfatides almost had no effect on BKCa(C646:647A) channels: Po only
changed from 1.2 ± 0.3% to 1.5 ± 0.4% (n = 6) (Fig. 2I). These results
suggest that palmitoylation of the STREX domain is necessary for the ce-
rebrosides to activate the BKCa channel.
3.2. Removal of palmitoylation sites in the STREX domain had no effect on
single channel conductance and voltage-dependence of the BKCa channel
Next, we tested whether the removal of palmitoylation sites in the
STREX domain inﬂuences the intrinsic properties of the BKCa channel.
As shown in Fig. 3A and B, there was no signiﬁcant difference in the sin-
gle channel unitary current amplitude between the wild-type and
C646:647A mutant BKCa channels. The single channel conductance
was 134.2 pS for the wild type channel, while it was 135.4 pS for the
BKCa(C646:647A) channel at +20 mV (Fig. 3C), indicating that the
removal of palmitoylation sites in the STREX domain does not change
the single channel conductance of the BKCa channel. To determine
whether the voltage-dependence of the channel was altered, the volt-
age dependence of activation was studied. The values of Po were ﬁtted
to the Boltzmann equation: Po = 1 / {1 + e[(V1/2 − V) / k]}, where V is
voltage, V1/2 is the voltage producing the half maximal activity and k
is the slope factor. Values of 68.1 ± 0.2 mV for V1/2 and 11.1 ± 0.1 mV
for k were obtained in the wild type BKCa channels (n = 25), and they
were 70.3 ± 0.2 mV and 11.1 ± 0.2 mV, respectively, for the
C646:647A mutant BKCa channel (n = 25) (Fig. 3D), indicating that
the voltage-sensitivity of the channel was not markedly altered by the
removal of palmitoylation in the STREX domain.
3.3. Palmitoylation was required for STREX fragment to associate with the
plasma membrane
Previous reports have demonstrated that palmitoylation could make
STREX containing fragments (STREXC-terminus or cysteine-rich domain)
Fig. 2.Removal of palmitoylation sites in STREXdomain abolished the ability of cerebrosides to activate the BKCa channel. (A, D andG) Representative single channel current traces for BKCa(WT) andBKCa(C646:647A) channels in the absence (control)
and presence of Baifuzi-CB (A), single CB (D) or sulfatides (G) at +20 mV. Arrows indicate the level that all channels in the patch membrane are in the closed state. (B, E and H) The two data points on each end of the line represent Po of the BKCa
channel before and after application of Baifuzi-CB (B), single CB (E) or sulfatides (H) from the same patchmembrane. (C, F and I) Statistical summary for the Po of the BKCa(WT) and BKCa(C646:647A) channels before and after application of Baifuzi-CB












Fig. 3. Effect of the removal of palmitoylation sites in the STREXdomain on single channel conductance and voltage-dependence of the BKCa channel. (A and B) Representative single chan-
nel current traces for BKCa(WT) and BKCa(C646:647A) channels from inside-out patches at a voltage range of−10 mV to +50 mV. (C) Single channel current–voltage relationship for
BKCa(WT) (n = 23) and BKCa(C646:647A) (n = 21) channels. The solid lines were obtained by the best ﬁt to data according to GHK current equation with Erev =−82.8 mV. (D) The
Po for BKCa(WT) (n = 25) and BKCa(C646:647A) (n = 25) channels at membrane potentials ranged from−40 to +60 mV.
Fig. 4. Palmitoylation is required for STREX fragment to associate with the plasma mem-
brane. (A and B) Representative single confocal sections from CHO cells expressing
STREX(WT) and STREX(C646:647A) constructs. (C and D) Representative single confocal
sections from STREX(WT) expressed in CHO cells that were pretreated with 100 μM 2-BP
overnight (C) or 6 μM TM for 2 h at 37 °C (D). Scale bar = 10 μm.
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fragment alone could target to the plasma membrane by palmitoylation,
we generated STREX(WT)-EGFP and STREX(C646:647A)-EGFP con-
structs. Transient expression of the STREX(WT)-EGFP in CHO cells result-
ed in robustﬂuorescence around theplasmamembrane (Figs. 4A and5A).
In the C646A:C647Amutant, even though the fusion proteinwas robustly
expressed, it only showed cytoplasmic distribution (Figs. 4B and 5B). Fur-
thermore, the plasma membrane localization of the STREX(WT) domain
was abolished by preincubation of cells with palmitic acid analog 2-
bromopalmitate (2-BP) or palmitoylation inhibitor tunicamycin (TM) in
CHO cells (Figs. 4C, D and 5C). To determine the location of the STREX do-
mainmore accurately,weused an anti-vimentin for immunoﬂuorescence
assay on HEK 293 cells. Vimentin is a type III intermediate ﬁlament, along
with tubulin-based microtubules and actin-based microﬁlaments, com-
prising the cytoskeleton. The merged images in HEK 293 cells showed
that thewide type STREX fragment could locate at the outside of vimentin
(white arrows in Fig. 6A), while the STREX(C646:647A) fragment could
overlap but not be able to locate to the outside of vimentin (white arrows
in Fig. 6B). These results indicate that palmitoylation could make the
STREX fragment alone target to the plasma membrane.
3.4. Prevention of palmitoylation abolished the ability of cerebrosides to
activate the BKCa channel
To further validate that palmitoylation is necessary for cerebrosides
to activate the BKCa channel, we compared channel susceptibility to ce-
rebrosides in the presence of 2-BP or TM. The single channel current
traces showed that the application of 10 μM Baifuzi-CB, single CB or
sulfatides respectively to the intracellular face of the inside-out patches
could only slightly or no longer activate the BKCa channel in cells
Fig. 5. Localization of the mutant STREX-C646:647A and 2-BP treated STREX domain. (A and B) Representative confocal images from CHO cells expressing STREX(WT)-EGFP or
STREX(C646:647A)-EGFP. (C) Representative confocal images from STREX(WT)-EGFP expressed in CHO cells that were pretreatedwith 100 μM2-BP. Twenty-four hours following trans-
fection cells were stained with 1 μM ER Tracker red and live cells analyzed by confocal microscopy. Scale bar = 10 μm.
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the Po of the BKCa channel was 1.6 ± 0.5% in the absence of sulfatides,
while it only increased to 1.9 ± 0.5% (n = 6) after the application of
10 μMsulfatides (Fig. 7B). Previously,we have shown that the therapeu-
tic effect of the traditional Chinesemedicine Baifuzi on rat MCAOmodel
of ischemic stroke is due to the ability of its cerebrosides to activate the
BKCa channel [8]. Therefore, we checked the effects of 2-BP on the rat
BKCa channels (rBK). We found that the rat BKCa channel could not be
activated by the single cerebroside that was puriﬁed from Baifuzi-CB
after the application of 2-BP (Fig. 8). These results indicate that
palmitoylation is necessary for cerebrosides to activate the BKCa
channel.
4. Discussion
In the present studywehave demonstrated that palmitoylation of the
STREX domain could make the domain associate with the plasma mem-
brane so that cerebrosides in the plasma membrane could interact with
the STREX domain in the membrane interface to activate the BKCa chan-
nel. Firstly, we found that the cerebrosides could not activate the BKCachannel with mutation at the palmitoylation sites (C646:647A) within
the STREX domain, indicating that mutation of palmitoylation sites in
STREXdomain abolished the BKCa channel activation by the cerebrosides.
Secondly, confocal images of STREX-EGFP fragments demonstrated that
palmitoylation of C646 and C647 targeted STREX domain to the plasma
membrane, while the STREX(C646:647A)-EGFPmutant resulted in cyto-
plasmic distribution, indicating that palmitoylation of the STREX domain
is required for its associationwith themembrane. Thirdly, palmitoylation
inhibitor or palmitic acid analog not only attenuated the activation of the
BKCa channel by the cerebrosides but also reduced the distribution of
STREX fragment around the plasmamembrane. Taken together, these re-
sults suggest that palmitoylation of the STREX domain is necessary for
cerebrosides to activate the BKCa channel.
It is noticed that Po of the BKCa channel is variable frompatch to patch
even in the control condition. To reliably calculate Po of the channel in a
patch, it is critical to know the number of channels in the patch. In prac-
tice, the number is estimated from the maximum number of channels
observed, which is usually underestimated even though it is judge by
the favorite condition for channel activation. In our experiment, we did
not ﬁgure out the reason, but found that the base lines were un-stable
Fig. 6. Palmitoylation leads the STREX fragment to associate with the plasma membrane in HEK 293 cells. (A and B) Representative confocal sections of HEK 293 cells expressing
STREX(WT)-EGFP (A) and STREX(C646:647A)-EGFP (B) constructs. Cells were transiently transfected into STREX(WT)-EGFP or STREX(C646:647A)-EGFP constructs. Red: Vimentin.
Green: STREX-EGFP. Blue: nuclei stained with DAPI. Scale bars = 10 μm.
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tials. This prevented us to estimate the number of channel in the patch
at the favorite condition for the BKCa channel activation. To reduce the in-
ﬂuence as less as possible, the control Po for each set of experiment was
obtained only from that set of experiment. Furthermore, we comparedFig. 7. Prevention of palmitoylation abolished the ability of cerebrosides to activate the BKCa(W
pretreatedwith 100 μM2-BP overnight (A) or 6 μMTM for 2 h (C) before and after application of
of the BKCa(WT) channel under the same conditions as that in A and C, respectively. *: P b 0.05the Po of the BKCa channel before and after application of different cere-
brosides from the same patch membrane (Fig. 2B, E and H). The data set
from the same patch membrane clearly indicated that cerebrosides in-
creased the BKCa(WT) channel activity in the most patch membranes,
while no longer or only weakly activated the BKCa(C646:647A) channel.T) channel. (A and C) Representative single BKCa(WT) channel current traces in CHO cells
10 μM Baifuzi-CB, single CB and sulfatides at+20mV. (B andD) Statistical summary for Po
compared to the control.
Fig. 8. 2-BP abolished the ability of the Baifuzi cerebroside to activate the rat BKCa(WT)
(rBK) channel. (A) Representative single BKCa(WT) channel current traces in CHO cells
pretreated with 100 μM 2-BP before and after application of 10 μM single CB that was pu-
riﬁed from Baifuzi-CB. (B) Statistical summary for Po of the BKCa(WT) channel in the ab-
sence and presence of 2-BP. *: P b 0.05 compared to the control.
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main conclusion that palmitoylation of the STREX domain is necessary
for cerebrosides to activate the BKCa channel. Interestingly, by comparing
the Po of the BKCa(WT) channel from the same patch membrane in the
absence and presence of cerebrosides, we found that all kinds of cerebro-
sides tested could not or only weakly activate the BKCa(WT) channel in
some of the patch membranes (Fig. 2B, E and H). As palmitoylation is a
dynamic process, it is impossible that all BKCa channels are palmitoylated
at the same time. If no or only few channels in a patch membrane were
palmitoylated, the STREX domain of these channels could not associate
with the membrane and not be able to interact with cerebrosides in
themembrane. This might be the reason why cerebrosides could not ac-
tivate the channels in some of the patch membranes. In contrast, cere-
brosides, without exception, could not activate the BKCa channel when
palmitoylation of STREX was abolished by site-directed mutagenesis or
pharmacological inhibition of palmitoylation (Figs. 2 and 7). These ob-
servations are in good consistence with the dynamic nature of protein
palmitoylation.
Many kinds of lipid molecules, including fatty acids [3,26,27], phos-
pholipids [5,28] and cholesterol [29,30], could modulate the function of
BKCa channels. For fatty acids, attributing to differences in surface
charges, negatively or positively charged head group with sufﬁciently
long (C N 8) carbon chain, they increase or decrease the BKCa channel
open probability, respectively, while neutral and short-chain lipids
have no effect on the channel activation [27]. For cholesterol, it has
been suggested that cholesterol induces structural stress in the mem-
brane which enhances the transition from the open to the close state
of the channel, and therefore results in the reduction in the Po of the
BKCa channel [29]. In addition, biophysical properties of the membrane,
such as membrane deformation [31,32] and membrane thickness [33,
34] can affect function of the BKCa channel as well. In our previous stud-
ies,we have demonstrated that the ability of cerebrosides to activate theBKCa channel is due to their direct interaction with the STREX domain
[8]. In the present study, we show that it is palmitoylation that makes
the STREX domain to associate with the plasma membrane, therefore
provides a platform for cerebrosides in the membrane to interact with
the STREX domain to activate the BKCa channel. Active components of
traditional Chinese medicines often have not been speciﬁed and mea-
sured precisely, which subsequently hinders the understanding of
their mechanism of action on a well-deﬁned molecular target and the
evaluation of their therapeutic efﬁcacy. This work illustrated themolec-
ular mechanism of how cerebrosides activated the BKCa channel and
provided a rational for the use of Baifuzi for treating stroke at themolec-
ular level.Acknowledgements
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